0001680581-20-000001.txt : 20200611 0001680581-20-000001.hdr.sgml : 20200611 20200610174713 ACCESSION NUMBER: 0001680581-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200611 DATE AS OF CHANGE: 20200610 EFFECTIVENESS DATE: 20200611 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fulcrum Therapeutics, Inc. CENTRAL INDEX KEY: 0001680581 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474839948 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-368703 FILM NUMBER: 20955625 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-651-8851 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001680581 Fulcrum Therapeutics, Inc. 26 LANDSDOWNE STREET CAMBRIDGE MA MASSACHUSETTS 02139 617-651-8851 DELAWARE None None Corporation true 2015 Robert Gould 26 Landsdowne Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Mark Levin 26 Landsdowne Street Cambridge MA MASSACHUSETTS 02139 Director James Geraghty 26 Landsdowne Street Cambridge MA MASSACHUSETTS 02139 Director Alan Ezekowitz 26 Landsdowne Street Cambridge MA MASSACHUSETTS 02139 Director James Collins 26 Landsdowne Street Cambridge MA MASSACHUSETTS 02139 Director Kate Haviland 26 Landsdowne Street Cambridge MA MASSACHUSETTS 02139 Director Katina Dorton 26 Landsdowne Street Cambridge MA MASSACHUSETTS 02139 Director Bryan Stuart 26 Landsdowne Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Owen Wallace 26 Landsdowne Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Diego Cadavid 26 Landsdowne Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Biotechnology Decline to Disclose 06b false 2020-06-09 false true false 0 SVB Leerink LLC 39011 None None 1 Federal Street 37th Floor Boston MA MASSACHUSETTS 02110 All States false 68499987 68499987 0 false 13 4109999 0 0 false Fulcrum Therapeutics, Inc. /s/ Robert Gould Robert Gould President and Chief Executive Officer 2020-06-10